CRL - Company ID 0001100682
The table below shows CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $995.83M | $1.00B | $1.03B | $984.17M | $1.01B | $1.03B |
| Cost of revenue | - | - | - | - | $660.74M | $672.40M |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported annual revenue of $4.02B for fiscal year 2025. That is down 0.9% from $4.05B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.68B (FY 2016) to $4.02B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $159.42M |
| $177.59M |
| $191.55M |
| $177.80M |
| $199.21M |
| $169.79M |
| Operating income | $119.90M | $133.80M | $100.13M | $74.67M | $117.41M | $151.65M |
| Income tax | -$15.14M | $31.64M | $18.73M | $10.10M | $20.95M | $25.39M |
| Net income | -$14.84M | $54.42M | $52.33M | $25.47M | $69.66M | $94.08M |
| EPS (diluted) | -$0.30 | $1.10 | $1.06 | $0.50 | $1.33 | $1.74 |